ImmuPharma plc (LON:IMM – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.90 ($0.02) and traded as low as GBX 1.65 ($0.02). ImmuPharma shares last traded at GBX 1.68 ($0.02), with a volume of 198,040 shares changing hands.
ImmuPharma Trading Up 1.4 %
The company has a market capitalization of £7.01 million, a P/E ratio of -168.25 and a beta of 1.53. The business has a 50 day moving average price of GBX 1.74 and a 200 day moving average price of GBX 1.90.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Featured Stories
- Five stocks we like better than ImmuPharma
- 3 Stocks to Consider Buying in October
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Dividend Capture Strategy: What You Need to Know
- Top-Performing Non-Leveraged ETFs This Year
- Differences Between Momentum Investing and Long Term Investing
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
